Aerobic fitness after JDM-a long-term follow-up study

Rheumatology (United Kingdom)

Volumn 52, Issue 2, 2013, Pages 287-295

  Mathiesen, Pernille R ^a   Ørngreen, Mette C ^b   Vissing, John ^b   Andersen, Lars B ^c   Herlin, Troels ^d   Nielsen, Susan ^b  

^a Holbaek University Hospital   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Fitness; Follow up; Jdm; Myositis; Vo2max

Indexed keywords

ADOLESCENT; ADULT; AEROBIC CAPACITY; ARTICLE; BICYCLE ERGOMETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; JUVENILE DERMATOMYOSITIS; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; DERMATOMYOSITIS; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; REGISTRIES; REMISSION INDUCTION; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84873807663     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes232     Document Type: Article

References (50)

1. Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002;47:118-23.
2. Takken T, Spermon N, Helders PJ, Prakken AB, van der Net J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003;30:1075-80.
3. Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum 2005;53: 173-7.
4. Drinkard BE, Hicks J, Danoff J, Rider LG. Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy. Can J Appl Physiol 2003;28:888-97.
5. Wiesinger GF, Quittan M, Nuhr M et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000;81:1-5.
6. Takken T, van der Net J, Helders PJ. The reliability of an aerobic and anaerobic exercise test in patients with juvenile onset dermatomyositis. J Rheumatol 2005;32: 734-9.
7. Takken T, van der Net J, Engelbert RH, Pater S, Helders PJ. Responsiveness of exercise parameters in children with inflammatory myositis. Arthritis Rheum 2008; 59:59-64.
8. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36-40.
9. Coyle K, Rother KI, Weise M et al. Metabolic abnormalities and cardiovascular risk factors in children with myositis. J Pediatr 2009;155:882-7.
10. Anderssen SA, Cooper AR, Riddoch C et al. Low cardiorespiratory fitness is a strong predictor for clustering of cardiovascular disease risk factors in children independent of country, age and sex. Eur J Cardiovasc Prev Rehabil 2007;14:526-531.
11. Sandvik L, Erikssen J, Thaulow E et al. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993;328:533-7.
12. Blair SN, Kohl HW 3rd, Paffenbarger RS Jr et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. J Am Med Assoc 1989; 262:2392-401.
13. Mathiesen PR, Heegaard HK, Herlin T et al. Long-term outcome in patients with juvenile dermatomyositis: a crosssectional follow-up study. Scan J Rheum 2012;1:50-8.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
15. Andersen LB, Harro M, Sardinha LB et al. Physical activity and clustered cardiovascular risk in children: a cross-sectional study (the European Youth Heart Study). Lancet 2006;368:299-304.
16. Eiberg S, Hasselstrom H, Gronfeldt V et al. Maximum oxygen uptake and objectively measured physical activity in Danish children 6-7 years of age: the Copenhagen school child intervention study. Br J Sports Med 2005;39: 725-30.
17. Mamen A, Resaland GK, Mo DA, Andersen LB. Comparison of peak oxygen uptake in boys exercising on treadmill and cycle ergometers. Gazz Med Ital Arch Sci Med 2008;167:15-21.
18. Ruperto N, Ravelli A, Pistorio A et al. The provisional Paediatric Rheumatology International Trials Organisation/ American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008;59:4-13.
19. Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008;58:571-6.
20. Andersen LB. A maximal cycle exercise protocol to predict maximal oxygen uptake. Scand J Med Sci Sports 1995;5: 143-6.
21. Borg GA. Perceived exertion. Exerc Sport Sci Rev 1974;2: 131-53.
22. Rider LG, Koziol D, Giannini EH et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 2010;62:465-72.
23. Lovell DJ, Lindsley CB, Rennebohm RM et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42: 2213-9.
24. Nielsen S, Ruperto N, Herlin T, Pedersen FK. The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19(4 Suppl 23):S50-4.
25. Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528-37.
26. Ruperto N, Ravelli A, Murray KJ et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003;42: 1452-9.
27. McClain JJ, Hart TL, Getz RS, Tudor-Locke C. Convergent validity of 3 low cost motion sensors with the ActiGraph accelerometer. J Phys Act Health 2010;7: 662-70.
28. Anderssen SA, Hansen BJ, Kolle E et al. Fysisk aktivitet blant voksne og eldre i Norge. Resultater fra en kartleggning i 2008 og 2009 [Physical activity among adults and elderly people in Norway]. Oslo: Helsedirektoratet Norway, 2009.
29. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76.
30. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
31. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23:469-80.
32. Zimmet P, Alberti KG, Kaufman F et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
33. Mathiesen P, Zak M, Herlin T, Nielsen SM. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol 2010;28:782-9.
34. Wiesinger GF, Quittan M, Nuhr M et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81:1-5.
35. Lundberg IE, Nader GA. Molecular effects of exercise in patients with inflammatory rheumatic disease. Nat Clin Pract Rheumatol 2008;4:597-604.
36. Nagaraju K, Rider LG, Fan C et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis 2006;3:2.
37. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371: 2201-12.
38. Ubogu EE, Ruff RL, Kaminski HJ.. Endocrine myopathies. In: Engel AG, Franzini-Armstrong C, eds. Myology, 3rd edn. New York: McGraw-Hill, 2004:1713-38.
39. Alexanderson H, Lundberg IE. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2005;17:164-71.
40. Rowland T. Effect of prolonged inactivity on aerobic fitness in children. J Sports Med Phys Fitness 1994;34: 147-55.
41. Resaland GK, Mamen A, Boreham C, Anderssen SA, Andersen LB. Cardiovascular risk factor clustering and its association with fitness in nine-year-old rural Norwegian children. Scand J Med Sci Sports 2010;20: e112-20.
42. Resaland GK, Andersen LB, Mamen A, Anderssen SA. Effects of a 2-year school-based daily physical activity intervention on cardiorespiratory fitness: the Sogndal school-intervention study. Scand J Med Sci Sports 2011; 21:302-9.
43. Jurca R, Lamonte MJ, Barlow CE et al. Association of muscular strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc 2005;37:1849-55.
44. Stump CS, Henriksen EJ, Wei Y, Sowers JR. The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 2006;38:389-402.
45. Pachman LM, Abbott K, Sinacore JM et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006;148:247-53.
46. Ravelli A, Trail L, Ferrari C et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res 2010;62:63-72.
47. Anderssen SA, Cooper AR, Riddoch C et al. Low cardiorespiratory fitness is a strong predictor for clustering of cardiovascular disease risk factors in children independent of country, age and sex. Eur J Cardiovasc Prev Rehabil 2007;14:526-31.
48. Kolle E, Steene-Johannessen J, Andersen LB, Anderssen SA. Objectively assessed physical activity and aerobic fitness in a population-based sample of Norwegian 9- and 15-year-olds. Scand J Med Sci Sports 2010;20:e41-7.
49. Dalakas MC. The molecular and cellular pathology of inflammatory muscle diseases. Curr Opin Pharmacol 2001; 1:300-6.
50. Lawson M. The benefits and limitations of a physical training programme in patients with inflammatory myositis. Curr Rheumatol 2001;3:317-24.